Athira Pharma regains Nasdaq minimum bid price compliance; delisting risk removed

LeonaBio, Inc.

Received Nasdaq notice on Oct 2, 2025 that closing bid price was $1.00+ for ten consecutive days.
Compliance with Nasdaq minimum bid requirement is regained and the matter is closed.
Previously notified of deficiency on Oct 16, 2024 when stock fell below $1.00 for 30 days.

LeonaBio, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-229293

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.